Table 1 Characteristics of included studies
From: Emotional impact of screening: a systematic review and meta-analysis
| Disease and Disease risk | Assessment method |
First Author Reference Number |
Measures (scale) | Groups (n) | Follow-up | Country |
|---|---|---|---|---|---|---|
| Screening for presence of Disease | ||||||
|
Abdominal Aortic
Aneurysms (AAA) |
Abdominal Ultrasound | Ashton[24] |
State anxiety (STAIa), Depression (HADSb), QoL (SF-36) | Not-screened (726), Screened (1230), Screen +ve (599), Screen -ve (631) | 6 weeks | UK |
| Type II diabetes | Random glucose blood test | Eborall[25] | State anxiety (STAIa), Depression (HADSb), QoL (SF-36) | Not-screened (444), Screened (2874), Screen +ve (880), Screen -ve (1687) |
12-15 months | UK |
| Park[30] | State anxiety (STAIa), QoL (SF-36) | Not-screened (168), Screened (64) | 6 weeks | UK | ||
| Osteoporosis | Bone mineral density measurement | Torgerson[26] | State anxiety (STAIa), QoL (SF-36) | Not-screened (605), Invited (611) | 2 years | UK |
| Colorectal Cancer |
Faecal occult blood test | Parker[27] | General Distress - Suicide | Not-screened (74,998), Invited(75,253) | 14 years | UK |
| Whynes[29] | QoL (NHPd) | Not-Screened (396), Screened (821) | 5 months | UK | ||
| Ovarian Cancer | CA-125 blood test, transvaginal sonography | Andersen[32] | QoL (SF-36) | Not-Screened (139), Screened (128) | 2 years | USA |
| Disease and Disease risk | Assessment method |
First Author Reference Number |
Measures (scale) | Groups (n) | Follow-up | Country |
| Screening for presence of Disease cont. | ||||||
| Prostate, Lung, Colorectal and Ovarian Cancer Screening | Digital rectal exam & PSA test (men), CA-125 blood test & transvaginal ultrasound (women), chest x- ray, flexible sigmoidoscopy. | Taylor [31] | QoL (SF-12) | Not-screened (217), Screened (215), Screen +ve (105), Screen -ve (61) | 12 months | USA |
| Peptic Ulcer |
Helicobacter pylori blood test. | Hansen [28] | QoL (SF-36) |
Not-screened (5,612), Screened (4,821) | 5 years | Denmark |
| Risk Assessment | ||||||
| Lung Cancer |
Genotyping (GSTM1 gene) | Sanderson[33] | Depression, State Anxiety (HADSb) |
Not-screened (18), Screened (43), Screen +ve (23), Screen -ve (20) |
1 week, 2 months | UK |
| McBride[34] |
Depression (CES-De) | EUC (115), Biomarker Feedback (236) | 12 months | USA | ||
|
Coronary Heart
Disease (CHD) | Additional risk factor for CHD | Christiansen[35] | General Distress (GHQc-12) | Not-screened (396), Screened (904) | 5 years | Denmark |
